MetaVia Inc. (NASDAQ:MTVA) IPO

MetaVia Inc.

IPO

Went public as Gemphire Therapeutics Inc. Priced at US$10.00 a share on Aug 4, 2016.

Price
US$10.00 a share
Shares offered
3,000,000 shares of common stock
Offering size
US$30 million
Underwriters' option
Up to 450,000 more shares
Listing
GEMP on the Nasdaq Global Market
Underwriters
Jefferies, RBC Capital Markets, Canaccord Genuity, Laidlaw & Company (UK) Ltd., LifeSci Capital · In the order on the cover
Shares delivered
On or about Aug 10, 2016

Steps

StepWhen
Draft sent to the SEC in confidenceSep 11, 2015
Filed publiclyApr 18, 2016
Amended twiceNewest Aug 4, 2016
Shares registered with an exchangeJun 20, 2016
Declared effective by the SECAug 4, 2016
Final prospectus, with the priceAug 8, 2016

From the cover of the final prospectus (424B4) filed Aug 8, 2016